rdf:type |
|
lifeskim:mentions |
|
pubmed:dateCreated |
1993-7-6
|
pubmed:abstractText |
Several retrospective analyses have recently shown the advantage of liver transplantation (OLT) for patients with hepatocellular carcinoma (HCC) at early tumor stages. Preliminary results of a prospective series of OLT for unresectable small HCC arising in cirrhosis are reported. Eighteen out of 22 patients (82%) are alive without evidence of HCC recurrence after a median follow-up of 11 months.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1046-7416
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
3
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
83-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7684917-Carcinoma, Hepatocellular,
pubmed-meshheading:7684917-Female,
pubmed-meshheading:7684917-Follow-Up Studies,
pubmed-meshheading:7684917-Hepatitis B,
pubmed-meshheading:7684917-Hepatitis C,
pubmed-meshheading:7684917-Humans,
pubmed-meshheading:7684917-Liver Cirrhosis,
pubmed-meshheading:7684917-Liver Neoplasms,
pubmed-meshheading:7684917-Liver Transplantation,
pubmed-meshheading:7684917-Male,
pubmed-meshheading:7684917-Middle Aged,
pubmed-meshheading:7684917-Neoplasm Recurrence, Local,
pubmed-meshheading:7684917-Neoplasm Staging,
pubmed-meshheading:7684917-Prognosis,
pubmed-meshheading:7684917-Prospective Studies,
pubmed-meshheading:7684917-Reoperation,
pubmed-meshheading:7684917-Survival Rate,
pubmed-meshheading:7684917-alpha-Fetoproteins
|
pubmed:year |
1993
|
pubmed:articleTitle |
Reappraisal of the role of liver transplantation in the treatment of hepatocellular carcinoma arising in cirrhosis.
|
pubmed:affiliation |
Department of Surgery, Istituto Nazionale Tumori, Milan, Italy.
|
pubmed:publicationType |
Journal Article
|